| Autor: |
Suzuki M; Second Department of Internal Medicine, Ehime University School of Medicine, Onsen-gun, Japan., Yoshii T, Ohtsuka T, Sasaki O, Hara Y, Okura T, Shigematsu Y, Hamada M, Hiwada K |
| Jazyk: |
angličtina |
| Zdroj: |
Angiology [Angiology] 2000 Dec; Vol. 51 (12), pp. 1031-4. |
| DOI: |
10.1177/000331970005101209 |
| Abstrakt: |
Myasthenia gravis (MG) is characterized by weakness of skeletal muscles because of a decrease in the number of available acetylcholine receptors at neuromuscular junctions. Anticholinesterase medication is widely used to treat MG, but muscarinic side effects sometimes appear and limit the drug usage. To their knowledge, the authors present the first case of coronary spastic angina quite possibly induced by anticholinesterase medication to treat MG. The appearance of coronary spastic angina in the present case is likely mediated through the increase of acethylcholine by anticholinesterase medication. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
